Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$19.56 - $32.94 $275,404 - $463,795
-14,080 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$22.73 - $36.04 $320,038 - $507,443
14,080 New
14,080 $380,000
Q1 2021

May 17, 2021

SELL
$35.94 - $52.67 $299,380 - $438,741
-8,330 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$38.43 - $47.36 $320,121 - $394,508
8,330 New
8,330 $345,000

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $675M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.